SuperworthDefinium Therapeutics shares outstanding DFTX
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 110.7M
- On a year earlier
- +29.7%
- more shares
Definium Therapeutics had 110.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 29.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 100.9M | +20% |
| FY2024 | 83.9M | +109% |
| FY2023 | 40.2M | +7% |
| FY2022 | 37.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 110.7M | +30% | |
| Q1 FY26 | 108.8M | +25% | |
| Q4 FY25 | 100.9M | +20% | |
| Q3 FY25 | 85.9M | +7% | |
| Q2 FY25 | 85.3M | +13% | |
| Q1 FY25 | 87.1M | +82% | |
| Q4 FY24 | 83.9M | +109% | |
| Q3 FY24 | 80.2M | +102% | |
| Q2 FY24 | 75.3M | +95% | |
| Q1 FY24 | 47.9M | +26% | |
| Q4 FY23 | 40.2M | +7% | |
| Q3 FY23 | 39.7M | +36% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Definium Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.